| Sat, Aug 23, 2008 | | • | ACCENTIA BIOPHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Aug 23)
| | Fri, Aug 15, 2008 | | • | Accentia Biopharmaceuticals sees Q3 loss narrow, receives Nasdaq notice
at bizjournals.com (Fri, Aug 15)
| | • | Accentia Biopharmaceuticals cuts loss as research costs drop
at bizjournals.com (Fri, Aug 15)
| | Thu, Aug 14, 2008 | | • | Accentia Reports Fiscal Third Quarter Financial Results
Business Wire (Thu, Aug 14)
| | • | ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Aug 14)
| | • | Q3 2008 ACCENTIA BIOPHARMACEUTICALS Earnings Release - Time Not Supplied
CCBN (Thu, Aug 14)
| | Tue, Aug 5, 2008 | | • | Biovest joins cancer research collaborative
at bizjournals.com (Tue, Aug 5)
| | • | Biovest Joins in the Formation of the Joint U.S.-Norway Cancer Research Program, a Collaborative Effort with Plans to Present to NCI and the U.S. Military Healthcare System
Business Wire (Tue, Aug 5)
| | Mon, Aug 4, 2008 | | • | ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under
EDGAR Online (Mon, Aug 4)
| | Fri, Jul 25, 2008 | | • | Biotech-Stock Mailbag: Genentech
at TheStreet.com (Fri, Jul 25)
| | Mon, Jul 21, 2008 | | • | Biovest Announces Conference Call / Webcast to Discuss Phase 3 BiovaxID(R) Anti-Cancer Vaccine Results
Business Wire (Mon, Jul 21)
| | Thu, Jul 17, 2008 | | • | Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
Business Wire (Thu, Jul 17)
| | Mon, Jul 14, 2008 | | • | ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statemen
EDGAR Online (Mon, Jul 14)
| | Mon, Jun 23, 2008 | | • | Accentia Biopharmaceuticals to Present at the Jefferies Second Annual Healthcare Conference
Business Wire (Mon, Jun 23)
| | Fri, Jun 20, 2008 | | • | ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct
EDGAR Online (Fri, Jun 20)
| | • | Biovest Misleading in BioVaxID Data
at Minyanville.com (Fri, Jun 20)
| | Wed, Jun 18, 2008 | | • | ACCENTIA BIOPHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct
EDGAR Online (Wed, Jun 18)
| | Tue, Jun 17, 2008 | | • | Accentia Biopharmaceuticals gets backing for key products
at bizjournals.com (Tue, Jun 17)
| | • | Accentia Reports on Multiple Sclerosis Study: Revimmune(R) Shows Unprecedented Results in Reducing Disability and Improving Functions
Business Wire (Tue, Jun 17)
| | • | Accentia Biopharmaceuticals Announces $8.5 Million Financing to Advance Key Strategies for SinuNase(TM) and Revimmune(TM)
Business Wire (Tue, Jun 17)
|
Add ABPI News to My Yahoo!:
 
| |
|
1.85% Nasdaq 
Headlines
